Risk factor
Very poor trading liquidity
Profitability factor
Very strong margins and returns
About
HeXun Biosciences Co., Ltd., a Taiwanese enterprise, focuses on the research, development, and application of stem cell technologies and treatments. The company also offers a comprehensive suite of related services, including contract development and manufacturing for various cell types and their derivatives, outsourced production capabilities, quality control inspections, expert consulting, laboratory information management system (LIMS) implementation, and sterile (aseptic) filling solutions. Founded in 2019, its operations are headquartered in Taoyuan City, Taiwan.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT